<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="6429" whole_study_id="6429" phs="000547" v="1" p="1" createDate="2010-09-30T13:35:00-05:00" modDate="2020-01-21T13:41:19-05:00" maxParentChildStudyModDate="2020-01-21T13:41:19-05:00" handle="GARNET_BreastCancer_Weinshilboum" num_participants=""><StudyInfo accession="phs000547.v1.p1" parentAccession="phs000547.v1.p1"><BioProject id="PRJNA175096" entrez_id="175096" type="bp_admin_access"/><BioProject id="PRJNA175097" entrez_id="175097" type="bp_data_submission"/><StudyNameEntrez>GARNET GWAS in Breast Cancer Patients from the SUCCESS trial</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="Yes"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType></StudyTypes><Funding>U01 HG005137-01</Funding></StudyInfo><Authority><ICs><IC id="15" name="NHGRI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="WEINSHILBOUM1" aid="2" auth="eRA" login="WEINSHILBOUM1" fname="Richard" mname="M" lname="Weinshilboum" email="weinshilboum.richard@mayo.edu"><Role allow_direct_access="true">PI</Role><Organization>MAYO CLINIC ROCHESTER</Organization></Person><Person nedid="0011195757" aid="1" auth="cit" login="maddeneb" fname="Ebony" mname="Bookman" lname="Madden" email="ebony.madden@nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0010170421" aid="1" auth="cit" login="strasbuj" fname="Jennifer" mname="A" lname="Strasburger" email="strasbuj@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><acknowledgement_statement>Funding support for the Genome-wide association study in breast cancer patients from the prospectively randomized SUCCESS-A trial was provided through the NHGRI Genomics and Randomized Trials Network [GARNET] (U01 HG005152). Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the GARNET Coordinating Center (U01 HG005157). 
Assistance with data cleaning was provided by the National Center for Biotechnology Information. Funding support for genotyping, which was performed at the Center for Inherited Disease Research (CIDR) at Johns Hopkins University, was provided by the NIH Genes, Environment and Health Initiative [GEI] (U01 HG005137). The datasets used for the analyses described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/sites/entrez?db=gap through dbGaP accession phs000547. </acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="328" CGType="cg_class_other" title="Breast cancer, study drug efficacy and toxicity, and covariates" name="BCETC" dac_uid="54" dac_name="NHGRI" irb-approval-required="No"><Use-Restriction>Limited to research within the study objectives, which are the efficacy of the study drugs and toxicity of the study drugs, quality of life and association with co-variates which have an influence on these outcome data. SUCCESS A is a breast cancer clinical trial. Study drugs include 5-flurouracil-epirubicin-cyclophosphamide (FEC), docetaxel and gemcitabine.  Covariates include: metastatic axillary lymph node involvement, hormone receptor status, menopausal status, age at treatment, CYP2D6 genotype.  Outcomes include: breast cancer-free survival and overall survival.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>